BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sun Y, Chen H, Dai J, Wan Z, Xiong P, Xu Y, Han Z, Chai W, Gong F, Zheng F. Glycyrrhizin Protects Mice Against Experimental Autoimmune Encephalomyelitis by Inhibiting High-Mobility Group Box 1 (HMGB1) Expression and Neuronal HMGB1 Release. Front Immunol 2018;9:1518. [PMID: 30013568 DOI: 10.3389/fimmu.2018.01518] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
Number Citing Articles
1 Yang E, Song I, Song K. Ethanol extract of Glycyrrhizae Radix modulates the responses of antigen-specific splenocytes in experimental autoimmune encephalomyelitis. Phytomedicine 2019;54:56-65. [DOI: 10.1016/j.phymed.2018.09.189] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
2 Gorgulho CM, Romagnoli GG, Bharthi R, Lotze MT. Johnny on the Spot-Chronic Inflammation Is Driven by HMGB1. Front Immunol 2019;10:1561. [PMID: 31379812 DOI: 10.3389/fimmu.2019.01561] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 8.3] [Reference Citation Analysis]
3 Xiao Y, Sun Y, Liu W, Zeng F, Shi J, Li J, Chen H, Tu C, Xu Y, Tan Z, Gong F, Shu X, Zheng F. HMGB1 Promotes the Release of Sonic Hedgehog From Astrocytes. Front Immunol 2021;12:584097. [PMID: 33868221 DOI: 10.3389/fimmu.2021.584097] [Reference Citation Analysis]
4 Nishibori M, Wang D, Ousaka D, Wake H. High Mobility Group Box-1 and Blood-Brain Barrier Disruption. Cells 2020;9:E2650. [PMID: 33321691 DOI: 10.3390/cells9122650] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
5 Paudel YN, Semple BD, Jones NC, Othman I, Shaikh MF. High mobility group box 1 ( HMGB 1) as a novel frontier in epileptogenesis: from pathogenesis to therapeutic approaches. J Neurochem 2019;151:542-57. [DOI: 10.1111/jnc.14663] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 10.7] [Reference Citation Analysis]
6 Somayajulu M, Mcclellan SA, Bessert DA, Pitchaikannu A, Hazlett LD. Ocular Effects of Glycyrrhizin at Acidic and Neutral pH. Front Cell Infect Microbiol 2022;11:782063. [DOI: 10.3389/fcimb.2021.782063] [Reference Citation Analysis]
7 Andersson U, Tracey KJ, Yang H. Post-Translational Modification of HMGB1 Disulfide Bonds in Stimulating and Inhibiting Inflammation. Cells 2021;10:3323. [PMID: 34943830 DOI: 10.3390/cells10123323] [Reference Citation Analysis]
8 Jiang L, Shao Y, Tian Y, Ouyang C, Wang X. Nuclear Alarmin Cytokines in Inflammation. J Immunol Res 2020;2020:7206451. [PMID: 33344656 DOI: 10.1155/2020/7206451] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Petrarca L, Manganelli V, Nenna R, Frassanito A, Ben David S, Mancino E, Garofalo T, Sorice M, Misasi R, Midulla F. HMGB1 in Pediatric COVID-19 Infection and MIS-C: A Pilot Study. Front Pediatr 2022;10:868269. [DOI: 10.3389/fped.2022.868269] [Reference Citation Analysis]
10 Saurin S, Meineck M, Erkel G, Opatz T, Weinmann-menke J, Pautz A. Drug Candidates for Autoimmune Diseases. Pharmaceuticals 2022;15:503. [DOI: 10.3390/ph15050503] [Reference Citation Analysis]
11 Anwar H, Rasul A, Iqbal J, Ahmad N, Imran A, Malik SA, Ijaz F, Akram R, Maqbool J, Sajid F, Sun T, Hussain G, Manzoor MF. Dietary biomolecules as promising regenerative agents for peripheral nerve injury: An emerging nutraceutical-based therapeutic approach. J Food Biochem 2021;:e13989. [PMID: 34719796 DOI: 10.1111/jfbc.13989] [Reference Citation Analysis]
12 Fuzimoto AD, Brigo F. The "Treatise on the spleen and stomach" (Pí Wèi Lùn) as the first record of multiple sclerosis in the medical literature - A hypothesis based on the analysis of clinical presentation and herbal medicine. J Tradit Complement Med 2020;10:288-300. [PMID: 32670824 DOI: 10.1016/j.jtcme.2020.02.009] [Reference Citation Analysis]
13 Li J, Shi J, Sun Y, Zheng F. Glycyrrhizin, a Potential Drug for Autoimmune Encephalomyelitis by Inhibiting High-Mobility Group Box 1. DNA Cell Biol 2018;37:941-6. [PMID: 30325653 DOI: 10.1089/dna.2018.4444] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
14 Paudel YN, Angelopoulou E, C BK, Piperi C, Othman I. High mobility group box 1 (HMGB1) protein in Multiple Sclerosis (MS): Mechanisms and therapeutic potential. Life Sciences 2019;238:116924. [DOI: 10.1016/j.lfs.2019.116924] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
15 Su X, Wang X, Gong F, Feng M, Bai J, Zhang R, Dang X. Oral treatment with glycyrrhizin inhibits NLRP3 inflammasome activation and promotes microglial M2 polarization after traumatic spinal cord injury. Brain Research Bulletin 2020;158:1-8. [DOI: 10.1016/j.brainresbull.2020.02.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
16 Paudel YN, Khan SU, Othman I, Shaikh MF. Naturally Occurring HMGB1 Inhibitor, Glycyrrhizin, Modulates Chronic Seizures-Induced Memory Dysfunction in Zebrafish Model. ACS Chem Neurosci 2021;12:3288-302. [PMID: 34463468 DOI: 10.1021/acschemneuro.0c00825] [Reference Citation Analysis]
17 Nishibori M, Mori S, Takahashi HK. Anti-HMGB1 monoclonal antibody therapy for a wide range of CNS and PNS diseases. J Pharmacol Sci 2019;140:94-101. [PMID: 31105025 DOI: 10.1016/j.jphs.2019.04.006] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 9.0] [Reference Citation Analysis]
18 Tan SW, Zhao Y, Li P, Ning YL, Huang ZZ, Yang N, Liu D, Zhou YG. HMGB1 mediates cognitive impairment caused by the NLRP3 inflammasome in the late stage of traumatic brain injury. J Neuroinflammation 2021;18:241. [PMID: 34666797 DOI: 10.1186/s12974-021-02274-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Zou H, Ming B, Li J, Xiao Y, Lai L, Gao M, Xu Y, Tan Z, Gong F, Zheng F. Extracellular HMGB1 Contributes to the Chronic Cardiac Allograft Vasculopathy/Fibrosis by Modulating TGF-β1 Signaling. Front Immunol 2021;12:641973. [PMID: 33777037 DOI: 10.3389/fimmu.2021.641973] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 Xue J, Suarez JS, Minaai M, Li S, Gaudino G, Pass HI, Carbone M, Yang H. HMGB1 as a therapeutic target in disease. J Cell Physiol 2021;236:3406-19. [PMID: 33107103 DOI: 10.1002/jcp.30125] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 5.5] [Reference Citation Analysis]
21 Yang G, Xue Z, Zhao Y. MiR-582-5p attenuates neonatal hypoxic-ischemic encephalopathy by targeting high mobility group box 1 (HMGB1) through inhibiting neuroinflammation and oxidative stress. Curr Neurovasc Res 2021. [PMID: 34751119 DOI: 10.2174/1567202618666211109102740] [Reference Citation Analysis]
22 Zhao Y, Tan SW, Huang ZZ, Shan FB, Li P, Ning YL, Ye SY, Zhao ZA, Du H, Xiong RP, Yang N, Peng Y, Chen X, Zhou YG. NLRP3 Inflammasome-Dependent Increases in High Mobility Group Box 1 Involved in the Cognitive Dysfunction Caused by Tau-Overexpression. Front Aging Neurosci 2021;13:721474. [PMID: 34539383 DOI: 10.3389/fnagi.2021.721474] [Reference Citation Analysis]
23 Gaikwad S, Puangmalai N, Bittar A, Montalbano M, Garcia S, McAllen S, Bhatt N, Sonawane M, Sengupta U, Kayed R. Tau oligomer induced HMGB1 release contributes to cellular senescence and neuropathology linked to Alzheimer's disease and frontotemporal dementia. Cell Rep 2021;36:109419. [PMID: 34289368 DOI: 10.1016/j.celrep.2021.109419] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Yang H, Andersson U, Brines M. Neurons Are a Primary Driver of Inflammation via Release of HMGB1. Cells 2021;10:2791. [PMID: 34685772 DOI: 10.3390/cells10102791] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Paudel YN, Angelopoulou E, Semple B, Piperi C, Othman I, Shaikh MF. Potential Neuroprotective Effect of the HMGB1 Inhibitor Glycyrrhizin in Neurological Disorders. ACS Chem Neurosci 2020;11:485-500. [PMID: 31972087 DOI: 10.1021/acschemneuro.9b00640] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
26 Kim SJ, Ryu MJ, Han J, Jang Y, Lee MJ, Ju X, Ryu I, Lee YL, Oh E, Chung W, Heo JY, Kweon GR. Non-cell autonomous modulation of tyrosine hydroxylase by HMGB1 released from astrocytes in an acute MPTP-induced Parkinsonian mouse model. Lab Invest 2019;99:1389-99. [PMID: 31043679 DOI: 10.1038/s41374-019-0254-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]